MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases

[1]  S. Mowla,et al.  miRNA therapeutics in cardiovascular diseases: promises and problems , 2015, Front. Genet..

[2]  Ryan M. O’Connell,et al.  Exosome-delivered microRNAs modulate the inflammatory response to endotoxin , 2015, Nature Communications.

[3]  Jianqiang Ye,et al.  Both MicroRNA-155 and Virus-Encoded MiR-155 Ortholog Regulate TLR3 Expression , 2015, PloS one.

[4]  Nilesh J Samani,et al.  MicroRNAs in cardiovascular disease: an introduction for clinicians , 2015, Heart.

[5]  H. Mankin,et al.  MicroRNA-155 expression is independently predictive of outcome in chordoma , 2015, Oncotarget.

[6]  Longlong Yang,et al.  Acute downregulation of miR-155 at wound sites leads to a reduced fibrosis through attenuating inflammatory response. , 2014, Biochemical and biophysical research communications.

[7]  E. Olson.  MicroRNAs as Therapeutic Targets and Biomarkers of Cardiovascular Disease , 2014, Science Translational Medicine.

[8]  Y. Suárez,et al.  Improved repair of dermal wounds in mice lacking microRNA-155 , 2014, Journal of cellular and molecular medicine.

[9]  Ramkumar Veppathur Mohan,et al.  MicroRNAs as pharmacological targets in diabetes. , 2013, Pharmacological research.

[10]  C. Bracken,et al.  Mutant p53 drives invasion in breast tumors through up-regulation of miR-155 , 2013, Oncogene.

[11]  Guido Marcucci,et al.  Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Deb,et al.  1,25-Dihydroxyvitamin D Promotes Negative Feedback Regulation of TLR Signaling via Targeting MicroRNA-155–SOCS1 in Macrophages , 2013, The Journal of Immunology.

[13]  Leon N. Schulte,et al.  Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing , 2012, Nucleic acids research.

[14]  F. Kiessling,et al.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. , 2012, The Journal of clinical investigation.

[15]  S. Safe,et al.  Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation , 2012, Breast Cancer Research and Treatment.

[16]  H. Mollenkopf,et al.  Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis , 2012, Proceedings of the National Academy of Sciences.

[17]  J. Qian,et al.  Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. , 2012, Free radical biology & medicine.

[18]  G. Rimbach,et al.  Anti-inflammatory potential of allyl-isothiocyanate – role of Nrf2, NF-κB and microRNA-155 , 2012, Journal of cellular and molecular medicine.

[19]  Ryan M. O’Connell,et al.  microRNA regulation of inflammatory responses. , 2012, Annual review of immunology.

[20]  Subbaya Subramanian,et al.  Circulating microRNAs as biomarkers: A new frontier in diagnostics , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  A. Tijsen,et al.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? , 2012, Circulation research.

[22]  H. Okada,et al.  MicroRNAs and STAT interplay. , 2012, Seminars in cancer biology.

[23]  Robert Kleemann,et al.  Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. , 2011, Atherosclerosis.

[24]  Susan R. Quinn,et al.  A trio of microRNAs that control Toll-like receptor signalling. , 2011, International immunology.

[25]  L. O’Neill,et al.  MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.

[26]  G. Rimbach,et al.  Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. , 2011, The Journal of nutritional biochemistry.

[27]  Chunmei Wang,et al.  Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1 , 2010, The Journal of Immunology.

[28]  C. Croce,et al.  Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. , 2010, Carcinogenesis.

[29]  Y. Zhuang,et al.  Identification of MyD88 as a novel target of miR‐155, involved in negative regulation of Helicobacter pylori‐induced inflammation , 2010, FEBS letters.

[30]  R. Medzhitov.  Inflammation 2010: New Adventures of an Old Flame , 2010, Cell.

[31]  D. Iliopoulos,et al.  The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.

[32]  Ryan M. O’Connell,et al.  Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.

[33]  Manuel A. S. Santos,et al.  MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[34]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[35]  Muller Fabbri,et al.  Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.

[36]  David Baltimore,et al.  MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.

[37]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[38]  F. Sim,et al.  Operative management of sacral chordoma. , 2005, The Journal of bone and joint surgery. American volume.

[39]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[40]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[41]  Brian Stramer,et al.  Wound healing and inflammation: embryos reveal the way to perfect repair. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  Ankush Gosain,et al.  Aging and Wound Healing , 2004, World Journal of Surgery.

[43]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[44]  M. Kubo,et al.  SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. , 2002, Immunity.

[45]  Warren S. Alexander,et al.  Suppressors of cytokine signalling (SOCS) in the immune system , 2002, Nature Reviews Immunology.

[46]  W. Tam.  Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. , 2001, Gene.

[47]  W. S. Hayward,et al.  bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA , 1997, Molecular and cellular biology.

[48]  J. Salisbury,et al.  The pathology of the human notochord , 1993, The Journal of pathology.

[49]  A. Mescher,et al.  Regenerative capacity and the developing immune system. , 2005, Advances in biochemical engineering/biotechnology.

[50]  R. Diegelmann,et al.  Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.